Risk factor
High price volatility
Profitability factor
Very strong margins and returns
About
Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China. The company provides Quetiapine XR for the treatment of Schizophrenia; and Dexlansoprazole DR capsules. It also develops ONCORE, a proprietary drug delivery technology that was developed to improve the patient compliance and safety...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Target Price
The average target price of 6620.TWO is 200 and suggests 63% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell